Densurank 60mg injection contains denosumab, a monoclonal antibody medicine used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It works by binding to and inhibiting a protein that plays a key role in bone breakdown, helping to increase bone density and reduce the risk of fractures. Densurank may also be used to manage bone loss associated with certain cancer therapies and other conditions that weaken bone strength. Your doctor will decide if this treatment is suitable for your condition.

Densurank 60mg injection is administered as a subcutaneous injection by a healthcare professional and should not be self-administered. The injection is typically given once every six months or as prescribed by your doctor. It may be administered in areas such as the upper arm, thigh, or abdomen. Adequate calcium and vitamin D intake may be recommended during treatment to support bone health.

Common side effects may include musculoskeletal pain such as bone, joint, or muscle pain, pain in the arms or legs, back pain, rash, headache, urinary tract infections, constipation, abdominal discomfort, and nerve pain. Rare but serious side effects can include low blood calcium levels, osteonecrosis of the jaw, atypical fractures, and increased susceptibility to infections. Contact your doctor immediately if you experience severe symptoms such as sudden jaw pain, significant bone or joint pain, or signs of low calcium.

Densurank 60mg injection is available from authorised pharmacies or speciality medicine suppliers with a valid prescription. Contact Macarius Health to check availability and pricing.

Store Densurank 60mg injection in a refrigerator between 2°C and 8°C. Do not freeze. Keep the injection in its original packaging to protect it from light and moisture, and keep it out of reach of children and pets. Follow all storage instructions provided by your healthcare provider or pharmacist.

Inform your doctor about all medicines, supplements, or herbal products you are taking. Some medicines, particularly those affecting calcium levels or bone metabolism, may interact with denosumab or increase the risk of side effects. Your doctor may adjust treatment or monitor you more closely if required.

Densurank 60mg injection is not recommended during pregnancy or while breastfeeding unless clearly advised by your doctor. Denosumab may harm an unborn baby and could pass into breast milk, potentially posing a risk to a nursing infant. Discuss risks, benefits, and effective contraception requirements with your healthcare provider before starting treatment.

Delivery time depends on stock availability and location. Macarius Health arranges prompt delivery within Delhi NCR. For other cities across India, delivery typically follows standard courier timelines.